Consistently, HHV-6A/6B reactivation has been associated with the occurrence of ME/CFS clinical symptoms and higher levels of proinflammatory cytokines, including tumor necrosis factor (TNF)-α, interleukin (IL)-6, and IL-12 [12,13]. Here, IL6 is linked to myalgic encephalomeyelitis/chronic fatigue syndrome.